Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:313 |
|---|---|
| Enthalten in: |
Archives of dermatological research - 313(2020), 2 vom: 09. Juli, Seite 127-128 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Talamonti, M. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: |
|---|
| doi: |
10.1007/s00403-020-02103-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR043023797 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR043023797 | ||
| 003 | DE-627 | ||
| 005 | 20230519155622.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210206s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00403-020-02103-z |2 doi | |
| 035 | |a (DE-627)SPR043023797 | ||
| 035 | |a (DE-599)SPRs00403-020-02103-z-e | ||
| 035 | |a (SPR)s00403-020-02103-z-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.93 |2 bkl | ||
| 100 | 1 | |a Talamonti, M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Tofani, L. |e verfasserin |4 aut | |
| 700 | 1 | |a Bianchi, L. |e verfasserin |4 aut | |
| 700 | 1 | |a Galluzzo, M. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of dermatological research |d Berlin : Springer, 1869 |g 313(2020), 2 vom: 09. Juli, Seite 127-128 |w (DE-627)SPR005032156 |w (DE-600)1458448-7 |x 1432-069X |7 nnns |
| 773 | 1 | 8 | |g volume:313 |g year:2020 |g number:2 |g day:09 |g month:07 |g pages:127-128 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00403-020-02103-z |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.93 |q ASE |
| 951 | |a AR | ||
| 952 | |d 313 |j 2020 |e 2 |b 09 |c 07 |h 127-128 | ||